Open access
Open access
Powered by Google Translator Translator

All Posts

[Abstract Only] Randomized trial: Carfilzomib, dexamethasone, and daratumumab vs. carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

22 Jul, 2020 | 02:11h | UTC

Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study – The Lancet

 


AHA scientific statement: Importance of housing and cardiovascular health and well-being

22 Jul, 2020 | 02:08h | UTC

Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association – Circulation: Cardiovascular Quality and Outcomes

News Release: Housing conditions affect cardiovascular health risks – American Heart Association

Top Things to Know: Importance of Housing and Cardiovascular Health and Well-Being

 


Phase 2 randomized trial: immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults

21 Jul, 2020 | 09:29h | UTC

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet

Commentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI

 

Related Commentary on Twitter

https://twitter.com/TheLancet/status/1285209554775617536

 


Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials

21 Jul, 2020 | 09:35h | UTC

Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet

Podcast: The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines

Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre

 


[Press release-based medicine…] Synairgen announces positive results from trial of SNG001 in hospitalized COVID-19 patients

21 Jul, 2020 | 09:27h | UTC

Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients

Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian

 


Phase 1/2 randomized trial: safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2

21 Jul, 2020 | 09:33h | UTC

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial – The Lancet

Commentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR

 

Related Commentary on Twitter

 


Survivorship after COVID-19 ICU stay

21 Jul, 2020 | 09:23h | UTC

Survivorship after COVID-19 ICU stay – Nature Reviews

 


[Preprint] Covid-19: Six clusters of symptoms could be used as a clinical prediction tool

21 Jul, 2020 | 09:25h | UTC

Symptom clusters in Covid19: A potential clinical prediction tool from the COVID Symptom study app – medRxiv

Commentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian

 


Modeling study: impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis

21 Jul, 2020 | 09:19h | UTC

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study – The Lancet Oncology

 

Related Commentary on Twitter

 


Thrombosis in hospitalized patients with COVID-19 in a New York City health system

21 Jul, 2020 | 09:21h | UTC

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA

 


[Abstract Only] Randomized trial: Dexmedetomidine does not decrease postoperative atrial arrhythmias or delirium in patients recovering from cardiac surgery

21 Jul, 2020 | 09:16h | UTC

Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial – The Lancet

 

Related Commentary on Twitter

https://twitter.com/NydahlPeter/status/1285199896958644231

 


Study: Increased incidence of ketoacidosis in children and adolescents with newly diagnosed Type 1 Diabetes during the COVID-19 pandemic

21 Jul, 2020 | 09:22h | UTC

Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany – JAMA

 


How (not) to write about global health

21 Jul, 2020 | 09:05h | UTC

How (not) to write about global health – The BMJ Global Health

 

Related Commentary on Twitter

 


Guideline: Diagnosing acute aortic syndrome

21 Jul, 2020 | 09:18h | UTC

Diagnosing acute aortic syndrome: a Canadian clinical practice guideline – Canadian Medical Association Journal

Commentary: New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome – News Medical

 


Podcast on acute kidney injury: myths & musings

21 Jul, 2020 | 08:59h | UTC

#226 Kidney Boy on Acute Kidney Injury: Myths & Musings – The Curbsiders Internal Medicine Podcast

 


Randomized trial: dexamethasone in hospitalized patients with Covid-19

20 Jul, 2020 | 08:18h | UTC

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report – New England Journal of Medicine

Commentary: Trial data support dexamethasone, but not hydroxychloroquine, for COVID-19 – CIDRAP

 

Related Commentary on Twitter

 


Burnout, a silent crisis in global health

21 Jul, 2020 | 09:00h | UTC

Burnout, A Silent Crisis In Global Health – Forbes

 

Related Commentary from the Author

 


The role of chest radiography in confirming Covid-19 pneumonia

20 Jul, 2020 | 08:13h | UTC

The role of chest radiography in confirming covid-19 pneumonia – The BMJ

 

Related Commentary on Twitter

 


Editorial: research in the context of a pandemic

20 Jul, 2020 | 08:16h | UTC

Research in the Context of a Pandemic – New England Journal of Medicine

 

Related Commentary on Twitter

 


Study: household transmission of SARS-CoV-2 is high if the index patient is 10–19 years of age

20 Jul, 2020 | 08:14h | UTC

Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 – CDC Emerging Infectious Diseases

Commentaries: Older Children Spread the Coronavirus Just as Much as Adults, Large Study Finds – The New York Times AND Children over age 10 spread COVID-19 as much as adults, study finds – CTV

 


Benefits of routine childhood vaccines far outweigh risks of additional COVID-19 transmission in Africa, modeling study suggests

20 Jul, 2020 | 08:07h | UTC

Benefits of routine childhood vaccines far outweigh risks of additional COVID-19 transmission in Africa, modelling study suggests – London School of Hygiene & Tropical Medicine

Original Study: Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection – The Lancet Global Health

 

Related Commentary on Twitter

 


Policy responses to the coronavirus pandemic

20 Jul, 2020 | 08:09h | UTC

Policy Responses to the Coronavirus Pandemic – Our World in Data

 


What counts as a Covid-19 death?

20 Jul, 2020 | 08:11h | UTC

What counts as a covid-19 death? – The BMJ

 


COVID-19 in people with diabetes: understanding the reasons for worse outcomes

20 Jul, 2020 | 08:06h | UTC

COVID-19 in people with diabetes: understanding the reasons for worse outcomes – The Lancet Diabetes & Endocrinology

Related: New-Onset Diabetes in Covid-19 – New England Journal of Medicine

 

Related Commentary on Twitter

 


Is coronavirus reinfection possible?

20 Jul, 2020 | 08:01h | UTC

Is Coronavirus Reinfection Possible? – Self

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.